Research

COGOBUY (400 HK)

Blazing Research may be a newcomer to the anonymous short-selling game, but its report on CogoBuy has credibility in key areas. The company’s founder has been accused of asset stripping his NASDAQ listed company, Viewtran, to the detriment of minorities, and then re-listing the assets in Hong Kong as CogoBuy. He is also accused of perpetuating Fake Cash Flow frauds at both CogoBuy and Viewtran. We have been able to verify the sequence of events that allowed Mr Kang to legally, if somewhat unethically, transfer these assets. The company’s rebuttal failed to address concerns. What’s to say he won’t repeat…
Read more ›

Log In

Insights

IN BRIEF: CTRIP (CTRP US)

Cashflow confusion questions premium rating

Mark Webb · 7 December 2017

Online travel agency Ctrip has delivered remarkable revenue growth. Moreover, despite the cost of integrating new businesses, Ctrip’s free cash flow also appears to have improved, with rising reported operating cashflow and falling capex. However, rather than indicating robust health, Ctrip’s headline performance shows how easily investors can be misled by the cashflow statement. The cashflow is primarily designed to assess liquidity and omits payments made using debt and equity rather than cash. In the case of Ctrip, if we include significant outflows from share-based staff pay and share-funded acquisitions in 2014-16, performance deteriorates from a headline free cash inflow…
Read more ›

IN-BRIEF: CHINA HONGQIAO (1378 HK)

Unresolved Issues (SELL/AVOID/SHORT)

Nigel Stevenson · 29 November 2017

China Hongqiao’s post-suspension share price appreciation might lead some to believe that fraud allegations have been addressed, but we are not entirely convinced. Even if investors can accept that the company had four different auditors in two years, they still have to grapple with a less than satisfactory response to fraud allegations and a very worrying set of financial statements containing similar traits to past frauds. The stock might be trading on 5x 2018 PER (assuming profits are real) but we would still be sellers. The cost of shorting is expensive at 9% but might be a strategy for risk…
Read more ›

COMING UP SHORT

Manipulating cash flows

Mark Webb · 22 November 2017

Investors increasingly view the income statement as unreliable; instead modelling cash flows to gauge performance. But the cash flow statement is flawed from an investment perspective as it only aims to reconcile movements in cash. This means that purchases funded with debt or equity are excluded which can materially distort operating and free cash flows. In this report, we discuss the most common practices affecting cash flows and highlight those stocks most impacted, such as China Southern, JD.com, Ctrip.com, China Resources Pharma and CKH Holdings. GET PDF VIEW SLIDES Payments using debt Items paid directly with debt, rather than cash,…
Read more ›

Free Newsletter

GET OUR FREE NEWSLETTER

Input your email address below to sign-up to our free newsletter.